Skip to main content
Erschienen in: Tumor Biology 7/2015

01.07.2015 | Research Article

Trends in gynaecological cancers in the largest obstetrics and gynaecology hospital in China from 2003 to 2013

verfasst von: XueLian Li, SaiHua Zheng, ShangJie Chen, Feng Qin, Sandy Lau, Qi Chen

Erschienen in: Tumor Biology | Ausgabe 7/2015

Einloggen, um Zugang zu erhalten

Abstract

The incidence and the trend of gynaecological cancers have been suggested to vary by ethnicity and geographical regions. Whether the incidence and type of gynaecological cancers in China is different have not been fully investigated. In this study, we reported the trend of gynaecological cancers in China. Data on 13,518 women with gynaecological cancers were collected from the largest obstetrics and gynaecology hospital in China from 2003 to 2013. Data included age at diagnosis and the annual number of women with diagnosed endometrial, ovarian, cervical cancer and other gynaecological cancers. The number of women with diagnosed gynaecological cancers increased by almost sixfold in 2013 compared to that in 2003. It was largely due to the increase of women with newly diagnosed cervical cancer. The percentage of women with endometrial and ovarian cancer within total gynaecological cancers was decreased, whilst the percentage of cervical cancer significantly increased between 2003 and 2013. The mean age of women with endometrial or ovarian cancer at diagnosis was 53 or 48 years, respectively, which was no difference over 11 years. However, the mean age of women with cervical cancer at diagnosis was significantly delayed from 42 years in 2003 to 46 years since 2011. This was also confirmed by the age-specific distribution of gynaecological cancers over 11 years. Our study found that the age onset of endometrial and ovarian cancer has not changed over 11 years. But the age onset of cervical cancer is delayed since 2011 in China.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Standards of service provision for gynaecological cancer patients in New Zealand - Provisional., M.o. Health, Editor. National Gynaecological Cancer Tumour Standards Working Group: Wellington; 2013. Standards of service provision for gynaecological cancer patients in New Zealand - Provisional., M.o. Health, Editor. National Gynaecological Cancer Tumour Standards Working Group: Wellington; 2013.
2.
Zurück zum Zitat Setiawan VW, Pike MC, Karageorgi S, Deming SL, Anderson K, Bernstein L, et al. National Endometrial Cancer Study, age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium. Am J Epidemiol. 2012;176(4):269–78.CrossRefPubMedPubMedCentral Setiawan VW, Pike MC, Karageorgi S, Deming SL, Anderson K, Bernstein L, et al. National Endometrial Cancer Study, age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium. Am J Epidemiol. 2012;176(4):269–78.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Olson SH, Atoria CL, Cote ML, Cook LS, Rastogi R, Soslow RA, et al. The impact of race and comorbidity on survival in endometrial cancer. Cancer Epidemiol Biomarkers Prev. 2012;21(5):753–60.CrossRefPubMed Olson SH, Atoria CL, Cote ML, Cook LS, Rastogi R, Soslow RA, et al. The impact of race and comorbidity on survival in endometrial cancer. Cancer Epidemiol Biomarkers Prev. 2012;21(5):753–60.CrossRefPubMed
4.
Zurück zum Zitat Jamison PM, Noone AM, Ries LA, Lee NC, Edwards BK. Trends in endometrial cancer incidence by race and histology with a correction for the prevalence of hysterectomy, SEER 1992 to 2008. Cancer Epidemiol Biomarkers Prev. 2013;22(2):233–41.CrossRefPubMed Jamison PM, Noone AM, Ries LA, Lee NC, Edwards BK. Trends in endometrial cancer incidence by race and histology with a correction for the prevalence of hysterectomy, SEER 1992 to 2008. Cancer Epidemiol Biomarkers Prev. 2013;22(2):233–41.CrossRefPubMed
5.
Zurück zum Zitat Cook LS, Kmet LM, Magliocco AM, Weiss NS. Endometrial cancer survival among U.S. black and white women by birth cohort. Epidemiology. 2006;17(4):469–72.CrossRefPubMed Cook LS, Kmet LM, Magliocco AM, Weiss NS. Endometrial cancer survival among U.S. black and white women by birth cohort. Epidemiology. 2006;17(4):469–72.CrossRefPubMed
6.
Zurück zum Zitat Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LAG, et al. Annual report to the nation on the status of cancer, 1975–2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst. 2005;97(19):1407.CrossRefPubMed Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LAG, et al. Annual report to the nation on the status of cancer, 1975–2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst. 2005;97(19):1407.CrossRefPubMed
7.
Zurück zum Zitat Cook LS WN, Doherty JA, Chen C. Endometrial cancer: cancer epidemiology and prevention. New York: Oxford University Press; 2006.CrossRef Cook LS WN, Doherty JA, Chen C. Endometrial cancer: cancer epidemiology and prevention. New York: Oxford University Press; 2006.CrossRef
8.
Zurück zum Zitat Howlader N, NA, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA. SEER Cancer Statistics Review, 1975–2011, National Cancer Institute. 2014. Howlader N, NA, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA. SEER Cancer Statistics Review, 1975–2011, National Cancer Institute. 2014.
10.
Zurück zum Zitat Galaal K, Al Moundhri M, Bryant A, Lopes AD, Lawrie TA. Adjuvant chemotherapy for advanced endometrial cancer. Cochrane Database Syst Rev. 2014;5:CD010681. Galaal K, Al Moundhri M, Bryant A, Lopes AD, Lawrie TA. Adjuvant chemotherapy for advanced endometrial cancer. Cochrane Database Syst Rev. 2014;5:CD010681.
11.
Zurück zum Zitat Armstrong EP. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types. J Manag Care Pharm. 2010;16(3):217–30.PubMed Armstrong EP. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types. J Manag Care Pharm. 2010;16(3):217–30.PubMed
12.
Zurück zum Zitat Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study. Lancet. 2012;380(9859):2095–128.CrossRefPubMed Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study. Lancet. 2012;380(9859):2095–128.CrossRefPubMed
13.
Zurück zum Zitat Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.CrossRefPubMed Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.CrossRefPubMed
14.
Zurück zum Zitat Gynaecological cancers in Australia: an overview: Australian Institute of Health and Welfare & Cancer Australia. 2012. Gynaecological cancers in Australia: an overview: Australian Institute of Health and Welfare & Cancer Australia. 2012.
15.
Zurück zum Zitat Kong A, Johnson N, Kitchener HC, Lawrie TA. Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis. J Natl Cancer Inst. 2012;104(21):1625–34.CrossRefPubMed Kong A, Johnson N, Kitchener HC, Lawrie TA. Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis. J Natl Cancer Inst. 2012;104(21):1625–34.CrossRefPubMed
16.
Zurück zum Zitat Lentz GM, L.R., Gershenson DM, Katz VL. Comprehensive gynecology 6th ed. Neoplastic diseases of the uterus: Mosby. 2013 Lentz GM, L.R., Gershenson DM, Katz VL. Comprehensive gynecology 6th ed. Neoplastic diseases of the uterus: Mosby. 2013
17.
Zurück zum Zitat Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, et al. Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(6):vi33–8.PubMed Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, et al. Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(6):vi33–8.PubMed
18.
Zurück zum Zitat Yang D, Haines CJ, Pan P, Zhang Q, Sun Y, Hong S, et al. Menopausal symptoms in mid-life women in southern China. Climacteric. 2008;11(4):329–36.CrossRefPubMed Yang D, Haines CJ, Pan P, Zhang Q, Sun Y, Hong S, et al. Menopausal symptoms in mid-life women in southern China. Climacteric. 2008;11(4):329–36.CrossRefPubMed
19.
Zurück zum Zitat Mahdi H, Schlick CJ, Kowk LL, Moslemi-Kebria M, Michener C. Endometrial cancer in Asian and American Indian/Alaskan native women: tumor characteristics, treatment and outcome compared to non-Hispanic white women. Gynecol Oncol. 2014;132(2):443–9.CrossRefPubMed Mahdi H, Schlick CJ, Kowk LL, Moslemi-Kebria M, Michener C. Endometrial cancer in Asian and American Indian/Alaskan native women: tumor characteristics, treatment and outcome compared to non-Hispanic white women. Gynecol Oncol. 2014;132(2):443–9.CrossRefPubMed
20.
Zurück zum Zitat Ries LAG, YJ, Keel GE, Eisner MP, Lin YD. Horner M-J SEER Survival monograph: cancer survival among adults: U.S. SEER Program, 1988–2001, Patient and Tumor Characteristics. National Cancer Institute. Chapter 16: Cancers of the Ovary. 2007. Ries LAG, YJ, Keel GE, Eisner MP, Lin YD. Horner M-J SEER Survival monograph: cancer survival among adults: U.S. SEER Program, 1988–2001, Patient and Tumor Characteristics. National Cancer Institute. Chapter 16: Cancers of the Ovary. 2007.
Metadaten
Titel
Trends in gynaecological cancers in the largest obstetrics and gynaecology hospital in China from 2003 to 2013
verfasst von
XueLian Li
SaiHua Zheng
ShangJie Chen
Feng Qin
Sandy Lau
Qi Chen
Publikationsdatum
01.07.2015
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 7/2015
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-3143-6

Weitere Artikel der Ausgabe 7/2015

Tumor Biology 7/2015 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.